PUBLISHER: KBV Research | PRODUCT CODE: 1155371
PUBLISHER: KBV Research | PRODUCT CODE: 1155371
Europe Left Atrial Appendage Closure Device Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Country and Growth Forecast, 2022 - 2028
The Europe Left Atrial Appendage (LAA) Closure Device Market would witness market growth of 18.6% CAGR during the forecast period (2022-2028).
The LAA is located near the apex of the upper left chamber of the heart. If the doctor recommends that blood clots in the LAA expose the patient to the risk for a stroke, they may be treated with blood thinners (anticoagulants) and other drugs that regulate their heartbeat. If these treatments are ineffective or patients are unable to tolerate them, the practitioner would suggest an LAA closure operation.
The treatment is effective because the left atrial appendage is sealed off. Ischemic stroke describes a stroke caused by a blood clot, especially one induced by atrial fibrillation (Afib). Ischemic strokes account for a significant proportion of all strokes among people all over the world. While LAA closure lessens the risk of cardiac blood clots, it is not a treatment for Afib. It neither stops the irregular or unpredictable pulse nor treats the underlying cause of Afib.
Effective therapy and management of Afib would depend on adhering to medical advice, including the use of any prescribed drugs or further treatments, as well as dietary and lifestyle modifications. There are several current devices and procedures for closing up the left atrial appendage. The medical team would review the different treatment choices with the patient and offer a recommendation based on their individual circumstances.
Atrial fibrillation is a very prevalent disease in several European countries. According to the European Society for Cardiology, it is the most prevalent cardiac rhythm disorder and accounts for approximately 0.28 to 2.6% of healthcare expenditures in European nations. Patients with atrial fibrillation above the age of 80 have an increased risk of stroke, therefore this demographic transition has major ramifications for the EU. Additionally, older people are more likely to have comorbidities associated with atrial fibrillation, such as heart failure or cognitive impairment. Thus, the rising prevalence of atrial fibrillation has bolstered the growth of the regional market.
The Germany market dominated the Europe Left Atrial Appendage (LAA) Closure Device Market by Country in 2021; thereby, achieving a market value of $270 million by 2028. The UK market is exhibiting a CAGR of 17.6% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 19.5% during (2022 - 2028).
Based on Application, the market is segmented into Geospatial Mapping, Disaster Management, Energy & Resource Management, Surveillance & Monitoring, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, AtriCure, Inc., Abbott Laboratories, Johnson & Johnson (Johnson & Johnson Services, Inc.), Occlutech Holding AG, LifeTech Scientific Corporation, Cardia, Inc. and Lepu Medical Technology Co., Ltd
Scope of the Study
Market Segments covered in the Report:
By End-use
- Hospital
- Ambulatory Surgery Centers
- Others
By Product
- Endocardial LAA Devices
- Epicardial LAA Devices
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Boston Scientific Corporation
- AtriCure, Inc.
- Abbott Laboratories
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Occlutech Holding AG
- LifeTech Scientific Corporation
- Cardia, Inc.
- Lepu Medical Technology Co., Ltd
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Left Atrial Appendage (LAA) Closure Device Market, by End-use
- 1.4.2 Europe Left Atrial Appendage (LAA) Closure Device Market, by Product
- 1.4.3 Europe Left Atrial Appendage (LAA) Closure Device Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition and scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Europe Left Atrial Appendage (LAA) Closure Device Market by End-use
- 3.1 Europe Hospital Market by Country
- 3.2 Europe Ambulatory Surgery Centers Market by Country
- 3.3 Europe Others Market by Country
Chapter 4. Europe Left Atrial Appendage (LAA) Closure Device Market by Product
- 4.1 Europe Endocardial LAA Devices Market by Country
- 4.2 Europe Epicardial LAA Devices Market by Country
Chapter 5. Europe Left Atrial Appendage (LAA) Closure Device Market by Country
- 5.1 Germany Left Atrial Appendage (LAA) Closure Device Market
- 5.1.1 Germany Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.1.2 Germany Left Atrial Appendage (LAA) Closure Device Market by Product
- 5.2 UK Left Atrial Appendage (LAA) Closure Device Market
- 5.2.1 UK Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.2.2 UK Left Atrial Appendage (LAA) Closure Device Market by Product
- 5.3 France Left Atrial Appendage (LAA) Closure Device Market
- 5.3.1 France Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.3.2 France Left Atrial Appendage (LAA) Closure Device Market by Product
- 5.4 Russia Left Atrial Appendage (LAA) Closure Device Market
- 5.4.1 Russia Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.4.2 Russia Left Atrial Appendage (LAA) Closure Device Market by Product
- 5.5 Spain Left Atrial Appendage (LAA) Closure Device Market
- 5.5.1 Spain Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.5.2 Spain Left Atrial Appendage (LAA) Closure Device Market by Product
- 5.6 Italy Left Atrial Appendage (LAA) Closure Device Market
- 5.6.1 Italy Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.6.2 Italy Left Atrial Appendage (LAA) Closure Device Market by Product
- 5.7 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market
- 5.7.1 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market by End-use
- 5.7.2 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market by Product
Chapter 6. Company Profiles
- 6.1 Boston Scientific Corporation
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Segmental and Regional Analysis
- 6.1.4 Research & Development Expenses
- 6.1.5 Recent strategies and developments:
- 6.1.5.1 Acquisition and Mergers:
- 6.1.5.2 Approvals and Trials:
- 6.1.6 SWOT Analysis
- 6.2 AtriCure, Inc.
- 6.2.1 Company Overview
- 6.2.2 Financial Analysis
- 6.2.3 Regional Analysis
- 6.2.4 Research & Development Expenses
- 6.2.5 Recent strategies and developments:
- 6.2.5.1 Acquisition and Mergers:
- 6.3 Abbott Laboratories
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Segmental and Regional Analysis
- 6.3.4 Research & Development Expenses
- 6.3.5 Recent strategies and developments:
- 6.3.5.1 Approvals and Trials:
- 6.3.6 SWOT Analysis
- 6.4 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 6.4.1 Company Overview
- 6.4.2 Financial Analysis
- 6.4.3 Segmental and Regional Analysis
- 6.4.4 Research & Development Expenses
- 6.4.5 SWOT Analysis
- 6.5 Occlutech Holding AG
- 6.5.1 Company Overview
- 6.5.2 Financial Analysis
- 6.5.3 Regional Analysis
- 6.5.4 Research & Development Expenses
- 6.6 LifeTech Scientific Corporation
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Segmental and Regional Analysis
- 6.6.4 Research & Development Expenses
- 6.7 Cardia, Inc.
- 6.7.1 Company Overview
- 6.8 Lepu Medical Technology Co., Ltd
- 6.8.1 Company Overview
LIST OF TABLES
- TABLE 1 Europe Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 2 Europe Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 3 Europe Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 4 Europe Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 5 Europe Hospital Market by Country, 2018 - 2021, USD Million
- TABLE 6 Europe Hospital Market by Country, 2022 - 2028, USD Million
- TABLE 7 Europe Ambulatory Surgery Centers Market by Country, 2018 - 2021, USD Million
- TABLE 8 Europe Ambulatory Surgery Centers Market by Country, 2022 - 2028, USD Million
- TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 11 Europe Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 12 Europe Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 13 Europe Endocardial LAA Devices Market by Country, 2018 - 2021, USD Million
- TABLE 14 Europe Endocardial LAA Devices Market by Country, 2022 - 2028, USD Million
- TABLE 15 Europe Epicardial LAA Devices Market by Country, 2018 - 2021, USD Million
- TABLE 16 Europe Epicardial LAA Devices Market by Country, 2022 - 2028, USD Million
- TABLE 17 Europe Left Atrial Appendage (LAA) Closure Device Market by Country, 2018 - 2021, USD Million
- TABLE 18 Europe Left Atrial Appendage (LAA) Closure Device Market by Country, 2022 - 2028, USD Million
- TABLE 19 Germany Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 20 Germany Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 21 Germany Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 22 Germany Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 23 Germany Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 24 Germany Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 25 UK Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 26 UK Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 27 UK Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 28 UK Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 29 UK Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 30 UK Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 31 France Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 32 France Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 33 France Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 34 France Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 35 France Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 36 France Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 37 Russia Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 38 Russia Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 39 Russia Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 40 Russia Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 41 Russia Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 42 Russia Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 43 Spain Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 44 Spain Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 45 Spain Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 46 Spain Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 47 Spain Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 48 Spain Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 49 Italy Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 50 Italy Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 51 Italy Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 52 Italy Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 53 Italy Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 54 Italy Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 55 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market, 2018 - 2021, USD Million
- TABLE 56 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market, 2022 - 2028, USD Million
- TABLE 57 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market by End-use, 2018 - 2021, USD Million
- TABLE 58 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market by End-use, 2022 - 2028, USD Million
- TABLE 59 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market by Product, 2018 - 2021, USD Million
- TABLE 60 Rest of Europe Left Atrial Appendage (LAA) Closure Device Market by Product, 2022 - 2028, USD Million
- TABLE 61 Key Information - Boston Scientific Corporation
- TABLE 62 Key Information - AtriCure, Inc.
- TABLE 63 Key Information - Abbott Laboratories
- TABLE 64 Key Information - Johnson & Johnson (Johnson & Johnson Services, Inc.)
- TABLE 65 Key Information - Occlutech Holding AG
- TABLE 66 Key Information - LifeTech Scientific Corporation
- TABLE 67 Key Information - Cardia, Inc
- TABLE 68 Key Information - Lepu Medical Technology Co., Ltd
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Boston Scientific Corporation
- FIG 3 SWOT Analysis: Boston Scientific Corporation
- FIG 4 Swot analysis: Abbott laboratories
- FIG 5 SWOT analysis: Johnson & Johnson
